Newsgather

cancer

مستقر342 خبر17 مصادرآخر تحديث: 4 sa önce

أحدث الأخبار

Study: Over 21 Ejaculations Per Month May Reduce Risk of Low-Risk Prostate Cancer
يتطور
صحة·2 g önceملخص الذكاء الاصطناعي

Study: Over 21 Ejaculations Per Month May Reduce Risk of Low-Risk Prostate Cancer

A large-scale study from Harvard University suggests that men ejaculating over 21 times per month may have a 19-22% lower risk of developing low-risk prostate cancer. However, frequent ejaculation showed no significant protective effect against high-risk or metastatic prostate cancer. Urologist Huang Po-jen emphasizes that this is an observational study showing correlation, not causation, and advises against deliberately altering ejaculation frequency for cancer prevention. He recommends a healthy lifestyle and regular screenings as the primary methods for prostate cancer prevention.

自由时报
Revolution Medicines' Experimental Drug Doubles Survival in Advanced Pancreatic Cancer
يتطور
صحة·2 g önceملخص الذكاء الاصطناعي

Revolution Medicines' Experimental Drug Doubles Survival in Advanced Pancreatic Cancer

Revolution Medicines' experimental drug, daraxonrasib, has shown unprecedented success in treating advanced pancreatic cancer, doubling patient survival rates and significantly reducing the risk of death by 60% compared to standard chemotherapy. The drug, a first-in-class RAS(ON) inhibitor, targets specific RAS gene mutations and demonstrated a remarkable improvement in tumor shrinkage and patient quality of life, with a much lower incidence of severe side effects. The FDA has granted it expanded access and speedy review.

C
Cumhuriyet
Chinese researchers' findings influencing global urological cancer treatment, says expert
يتطور
صحة·2 g önceملخص الذكاء الاصطناعي

Chinese researchers' findings influencing global urological cancer treatment, says expert

Chinese urological cancer experts are now influencing global treatment models, according to Professor Ye Dingwei. At the 2026 ASCO annual meeting, five studies from China were presented, with Ye's team from Fudan University Shanghai Cancer Center contributing three oral presentations on bladder and prostate cancer. Their research focuses on optimizing perioperative strategies, first-line treatments for advanced cancers, and salvage therapies for drug-resistant cases, marking a shift from surgical platforms to comprehensive treatment and original research.

中国新闻网
Jessie J and other Western stars find lucrative market in China
يتطور
Business·2 g önceملخص الذكاء الاصطناعي

Jessie J and other Western stars find lucrative market in China

Jessie J, Jessica Cornish, is finding success in China's music market, performing on the show "Singer" and adapting lyrics to local cities. The Chinese market, strengthened by copyright laws and post-Covid industry growth, is lucrative for Western artists like Westlife and Charli XCX, who adapt to local preferences for melody and vocal technique, despite challenges like censorship and tattoo visibility rules.

G
Guardian International
Taiwan's Insurance Bureau Excludes Home Cancer Chemotherapy from New In-Home Acute Care Insurance
خبر
4 g önceملخص الذكاء الاصطناعي

Taiwan's Insurance Bureau Excludes Home Cancer Chemotherapy from New In-Home Acute Care Insurance

Taiwan's Insurance Bureau has excluded home cancer chemotherapy from new in-home acute care insurance due to a lack of statistical data on its incidence. Current policies only cover pneumonia, urinary tract infections, and soft tissue infections. Insurers will use data from these three conditions to develop future policies for home cancer treatment.

自由时报